生物
胆管上皮细胞
肝移植
胆道
胆管
胆管疾病
移植
纤维化
胆道疾病
胆道闭锁
疾病
胃肠病学
癌症研究
病理
内科学
医学
内分泌学
作者
John M. Hallett,Sofía Ferreira-González,Tak Yung Man,Alastair M. Kilpatrick,Hannah Esser,Kayleigh Thirlwell,Mark T. Macmillan,Daniel Rodrigo‐Torres,Benjamin J. Dwyer,Victoria L. Gadd,Candice Ashmore‐Harris,Wei‐Yu Lu,John P. Thomson,Maurits A. Jansen,Eoghan O’Duibhir,Philip J. Starkey Lewis,Lara Campana,Rhona Aird,Thomas S. R. Bate,Alasdair R. Fraser
出处
期刊:Cell Stem Cell
[Elsevier BV]
日期:2022-03-01
卷期号:29 (3): 355-371.e10
被引量:57
标识
DOI:10.1016/j.stem.2022.02.006
摘要
Biliary diseases can cause inflammation, fibrosis, bile duct destruction, and eventually liver failure. There are no curative treatments for biliary disease except for liver transplantation. New therapies are urgently required. We have therefore purified human biliary epithelial cells (hBECs) from human livers that were not used for liver transplantation. hBECs were tested as a cell therapy in a mouse model of biliary disease in which the conditional deletion of Mdm2 in cholangiocytes causes senescence, biliary strictures, and fibrosis. hBECs are expandable and phenotypically stable and help restore biliary structure and function, highlighting their regenerative capacity and a potential alternative to liver transplantation for biliary disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI